Why the study?
Does enzyme induction with phenobarbital or phenytoin increase defluorination and nephrotoxicity risk following methoxyflurane, enflurane, or isoflurane anesthesia in rats?
Does enzyme induction with phenobarbital or phenytoin increase defluorination and nephrotoxicity risk following methoxyflurane, enflurane, or isoflurane anesthesia in rats?
Enzyme-inducing drugs like phenobarbital or phenytoin increase the risk of nephrotoxicity specifically when methoxyflurane is used as the anesthetic agent, due to increased defluorination.
Answers are grounded in this paper and cite their sources.
May increase methoxyflurane nephrotoxicity risk under enzyme induction in rats; leaves open human relevance and effects with other anesthetics.
Nephrotoxicity following administration of methoxyflurane has been shown to be directly related to anesthetic metabolism to inorganic fluoride. Enzyme induction should increase metabolic rate and the amount of inorganic fluoride that is released. In vivo studies in Fischer 344 rats show that enzyme induction with phenobarbital or phenytoin increases defluorination following methoxyflurane anesthesia but not after enflurane or isoflurane. In vitro, methoxyflurane defluorinase activity was increased far more than that of any of the other anesthetics. These data suggest that treatment with enzyme inducing drugs increases the risk of nephrotoxocity only if methoxyflurane is the anesthetic agent.
No takes yet. Share an insight, caveat, or question.
Hitt et al. (1977) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: